When Will Male Contraceptive Pills Be Available? Experts Explain the Latest Developments

Researchers are exploring hormone-free contraceptive pills for men, with YCT-529 emerging as one of the notable candidates. Developed by US-based YourChoice Therapeutics, the experimental oral contraceptive targets retinoic acid receptor alpha (RAR-α), a protein involved in sperm development in the testes. By blocking this signalling pathway, the drug aims to reduce sperm production without relying on hormonal suppression. An initial human study involving 16 healthy men examined the drug’s safety, its effects on the body, hormone levels, mood and sexual desire. Researchers reported no serious adverse effects in these early tests. However, these preliminary findings do not establish that the pill can effectively prevent pregnancy. Further clinical trials are needed to assess its effectiveness, long-term safety, effects on sperm production and whether fertility returns to normal after treatment is discontinued.

Separately, researchers at Weill Cornell Medicine in the United States are investigating another experimental approach designed to temporarily stop sperm movement using a pill taken before sexual intercourse. The proposed method is intended to be taken approximately 30 minutes before sex, with researchers targeting an effect lasting six to eight hours. These timings remain proposed targets and require confirmation through appropriate studies. Further safety assessments and research into effectiveness are necessary before human use can be considered. The two approaches are separate research projects, and neither is currently approved for routine use as a male contraceptive pill. Their availability will depend on the results of further studies assessing safety, effectiveness and long-term outcomes. Until approved alternatives become available, people should continue using established contraceptive methods. Condoms remain particularly important because they also help reduce the risk of sexually transmitted infections.